Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 13 matching records.
13 results — page 1 of 1
- Level DNarrative ReviewEurope PMC
Therapeutic potential of human umbilical cord mesenchymal stem cell-derived exosomes in myocardial infarction: from molecular mechanisms to clinical translation-an update
Narrative Review on Cardiovascular Disease, Immune Modulation, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol - Level BClinical TrialEurope PMC
Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes
Clinical Trial on Immune Modulation, published in J Clin Med (2021) — summary generated from the PubMed abstract.
- 2021
J Clin Med136 citations - Level DNarrative ReviewEurope PMC
Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies
Narrative Review on Immune Modulation, Autoimmune Research, published in EBioMedicine (2021) — summary generated from the PubMed abstract.
- 2021
EBioMedicine53 citations - Level ASystematic ReviewEurope PMC
Clinical applications of mesenchymal stromal cell-based therapies for pulmonary diseases: An Update and Concise Review
Systematic Review on Immune Modulation, published in Int J Med Sci (2021) — summary generated from the PubMed abstract.
- 2021
Int J Med Sci26 citations - Level BClinical TrialEurope PMC
Clinical update on the use of mesenchymal stem cells in COVID-19
Clinical Trial with a reported sample of 19, published in Am J Transl Res (2021) — summary generated from the PubMed abstract.
- 2021
- n = 19
Am J Transl Res5 citations - Level BClinical TrialEurope PMC
An Update on the Progress of Isolation, Culture, Storage, and Clinical Application of Human Bone Marrow Mesenchymal Stem/Stromal Cells
Clinical Trial on Immune Modulation, published in Int J Mol Sci (2020) — summary generated from the PubMed abstract.
- 2020
Int J Mol Sci176 citations - Level AMeta-analysisEurope PMC
Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis
Meta-analysis with a reported sample of 2696, published in EClinicalMedicine (2020) — summary generated from the PubMed abstract.
- 2020
- n = 2696
EClinicalMedicine210 citations - Level DNarrative ReviewEurope PMC
Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications
Narrative Review on Immune Modulation, Autoimmune Research, published in Cells (2020) — summary generated from the PubMed abstract.
- 2020
Cells100 citations - Level BClinical TrialPubMed
An updated review of adipose derived-mesenchymal stem cells and their applications in musculoskeletal disorders.
Clinical Trial on Tendon Injury, Chronic Inflammation, Autoimmune Research, published in Expert Opin Biol Ther (2019) — summary generated from the PubMed abstract.
- 2019
Expert Opin Biol Ther30 citations - Level BClinical TrialEurope PMC
Regenerative potential of the cartilaginous tissue in mesenchymal stem cells: update, limitations, and challenges
Clinical Trial on Cartilage Damage, published in Rev Bras Ortop (2017) — summary generated from the PubMed abstract.
- 2017
Rev Bras Ortop11 citations - Level BClinical TrialEurope PMC
Cartilage repair by mesenchymal stem cells: Clinical trial update and perspectives
Clinical Trial on Osteoarthritis, Cartilage Damage, published in J Orthop Translat (2017) — summary generated from the PubMed abstract.
- 2017
J Orthop Translat140 citations - Level BClinical TrialEurope PMC
Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials
Clinical Trial on Neuroinflammation, Immune Modulation, published in World J Stem Cells (2016) — summary generated from the PubMed abstract.
- 2016
World J Stem Cells28 citations - Level BClinical TrialPubMed
An update of human mesenchymal stem cell biology and their clinical uses.
Clinical Trial, published in Arch Toxicol (2014) — summary generated from the PubMed abstract.
- 2014
Arch Toxicol
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406